tiprankstipranks
Lyra Therapeutics (LYRA)
NASDAQ:LYRA
US Market

Lyra Therapeutics (LYRA) Balance Sheet

178 Followers

Lyra Therapeutics Balance Sheet

Lyra Therapeutics's total assets for Q4 2023 were $142.60M, an increase of 18.27% from the previous quarter. LYRA total liabilities were $53.18M for the fiscal quarter, a 46.36% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 142.60M$ 109.97M$ 54.87M$ 80.83M$ 14.96M
Total Liabilities
$ 53.18M$ 29.21M$ 20.55M$ 6.34M$ 138.30M
Total Equity Gross Minority
$ 89.38M$ 80.73M$ 34.32M$ 74.49M$ -123.34M
Total Capitalization
$ 110.87M$ 81.42M$ 34.32M$ 74.49M$ -123.34M
Preferred Stock Equity
-----
Capital Lease Obligations
---$ 2.44M$ 3.33M
Currency in USD

Lyra Therapeutics Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis